Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
<p>Abstract</p> <p>Background</p> <p>The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the...
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
BMC
2012-12-01
|
| Collection: | BMC Cancer |
| Sujets: | |
| Accès en ligne: | http://www.biomedcentral.com/1471-2407/12/585 |